Human immunodeficiency virus fitness in vivo: Calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase

Journal of Virology

Volumn 70, Issue 8, 1996, Pages 5662-5664

  Goudsmit, Jaap ^a   De Ronde, Anthony ^a   Ho, David D ^b   Perelson, Alan S ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c LOS ALAMOS NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RNA DIRECTED DNA POLYMERASE; SERINE; TYROSINE; ZIDOVUDINE;

ARTICLE; CALCULATION; CASE REPORT; DRUG RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTRAVENOUS DRUG ABUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; VIRUS INFECTION;

EID: 0030011523     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.8.5662-5664.1996     Document Type: Article

References (16)

1. Coffin, J. M. 1995. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267:483-489.
2. Cornelissen, M., G. Mulder-Kampinga, J. Veenstra, F. Zorgdrager, C. Kuiken, S. Hartman, J. Dekker, L. Van der Hoek, C. Sol, R. Coutinho, and J. Goudsmit. 1995. Syncytium-inducing (SI) phenotype suppression at sero-conversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population. J. Virol. 69:1810-1818.
3. de Ronde, A., R. Schuurman, J. Goudsmit, A. Van den Hoek, and C. Boucher. 1996. First case of new infection with zidovudine-resistant HIV-1 among prospectively studied intravenous drug users and homosexual men in Amsterdam, The Netherlands. AIDS 10:231-232.
4. Domingo, E., J. Holland, C. Biebricher, and M. Eigen. 1995. Quasispecies: the concept and the word, p. 181-191. In A. Gibbs, C. H. Calisher, and F. Garcia-Arenal (ed.), Molecular basis of virus evolution. Cambridge University Press, Cambridge.
5. Ho, D. D., A. U. Neumann, A. S. Perelson, W. Chen, J. M. Leonard, and M. Markowitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 373:123-126.
6. Holland, J. J., J. C. de la Torre, D. K. Clarke, and E. Duarte. 1991. Quantitation of relative fitness and great adaptability of clonal populations of RNA viruses. J. Virol. 65:2960-2967.
7. Kaye, S., C. Loveday, and R. S. Tedder. 1992. A microtitre format point mutation assay: application to the detection of drug-resistance in human immunodeficiency virus type 1-infected patients treated with zidovudine. J. Med. Virol. 37:241-246.
8. Lacey, S. F., and B. A. Larder. 1994. Mutagenic study of codons 74 and 215 of the human immunodeficiency virus type 1 reverse transcriptase, which arc significant in nucleoside analog resistance. J. Virol. 68:3421-3424.
9. Larder, B. A. 1994. Interactions between drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase. J. Gen. Virol. 75:951-957.
10. Mohri, H., M. K. Singh, W. T. Ching, and D. D. Ho. 1993. Quantitation of zidovudine-resistant human immunodeficiency virus type 1 in the blood of treated and untreated patients. Proc. Nail. Acad. Sci. USA 90:25-29.
11. Nagylaki, T. 1992. Introduction to theoretical population genetics, p. 25-27. Springer-Verlag KG, Berlin.
12. Najera, I., A. Holguin, M. E. Quinones-Mateu, M. A. Munoz-Fernandez, R. Najera, C. Lopez-Galindez, and E. Domingo. 1995. pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. J. Virol. 69:23-31.
13. Nijhuis, M., C. A. B. Boucher, and R, Schuurman. 1995. Sensitive procedure for the amplification of HIV-1 RNA using a combined reverse-transcription and amplification reaction. BioTechniques 19:178-180.
14. Novella, I. S., E. A. Duarte, S. F. Elena, A. Moya, E. Domingo, and J. J. Holland. 1995. Exponential increases of RNA virus fitness during large population transmissions. Proc. Natl. Acad. Sci. USA 92:5841-5844.
15. Perelson, A., A. U. Neumann, M. Markowitz, J. M. Leonard, and D. D. Ho. 1996. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271:1582-1586.
16. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, et al. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 373:117-122.